Inventor · disambiguated record
Ruth Tenengauzer
Also filed as: TENENGAUZER RUTH
7 granted patents·21 pending applications·75 citations·filing 2001–2013
85Inventor score
Top patents by PatentIndex Score
28 records- 0186US6764997B2Stabilized azithromycin compositionsTEVA PHARMA·Filed 2002·Granted Jul 20, 2004·29 cites·59 claims
- 0283US6897340B2Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMA·Filed 2003·Granted May 24, 2005·11 cites·39 claims
- 0382US7749536B2Pharmaceutical formulations of aliphatic amine polymers and methods for their manufactureTEVA PHARMA·Filed 2006·Granted Jul 6, 2010·8 cites·26 claims
- 0480US8865722B2Wet formulations of aripiprazoleHRAKOVSKY JULIA·Filed 2006·Granted Oct 21, 2014·3 cites·22 claims
- 0577US7572641B2Pharmaceutical compositions comprising meloxicam and methods of their preparationTEVA PHARMA·Filed 2005·Granted Aug 11, 2009·3 cites·21 claims
- 0677US6689384B2Stable pergolide mesylate and process for making sameTEVA PHARMA·Filed 2001·Granted Feb 10, 2004·14 cites·22 claims
- 0769US6482417B2Stable pharmaceutical formulation comprising torsemide modification IITEVA PHARMA·Filed 2001·Granted Nov 19, 2002·7 cites·19 claims
- 0859US2008161607A1Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMA·Filed 2008·Application pending·0 cites
- 0958US2005106239A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 1057US2008058404A1Stable pharmaceutical compositions of 2-aza-bicyclo [3.3.0]-octane-3-carboxylic acid derivativesTEVA PHARMA·Filed 2007·Application pending·0 cites
- 1157US2004192622A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 1257US2007154545A1Dry formulations of aripiprazoleHRAKOVSKY JULIA·Filed 2006·Application pending·0 cites
- 1356US2007213404A1Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMACEUTICAL USA INC·Filed 2007·Application pending·0 cites
- 1455US2013344146A1Dry formulations of aripiprazoleHRAKOVSKY JULIA·Filed 2013·Application pending·0 cites
- 1555US2007212409A1Stable pharmaceutical compositions for 2-aza-bicyclo [3.30]-octane-3-carboxylic acid derivativesHRAKOVSHY JULIA·Filed 2007·Application pending·0 cites
- 1652US2005069586A1Stable pharmaceutical compositions of 2-aza-bicyclo [3.3.0]-octane-3-carboxylic acid derivativesFiled 2004·Application pending·0 cites
- 1752US2005209342A1Processes for preparation of polymorphic form II of sertraline hydrochlorideBOROCHOVITCH RONEN·Filed 2005·Application pending·0 cites
- 1852US2007184101A1Stable pharmaceutical formulations of montelukast sodiumTEVA PHARMA·Filed 2006·Application pending·0 cites
- 1951US2006188569A1Stable pharmaceutical formulations of zonisamide and methods for their manufactureTEVA PHARMA·Filed 2006·Application pending·0 cites
- 2049US2007014864A1Novel pharmaceutical granulateTEVA PHARMA·Filed 2005·Application pending·0 cites
- 2149US2008149521A9Methods of stabilizing azithromycinPESACHOVICH MICHAEL·Filed 2006·Application pending·0 cites
- 2248US2007184108A1Stable pharmaceutical formulations of montelukast sodiumHRAKOVSKY JULIA·Filed 2006·Application pending·0 cites
- 2346US2006198895A1Azithromycin powder for oral suspension compositionsKOTLIAR ELEONORA M·Filed 2005·Application pending·0 cites
- 2443US2010120848A1Stable pharmaceutical formulations of montelukast sodiumTEVA PHARMA·Filed 2010·Application pending·0 cites
- 2542US2007014854A1Novel granulation processZALIT ILAN·Filed 2005·Application pending·0 cites
- 2642US2007014853A1Pharmaceutical dosage form containing novel pharmaceutical granulateZALIT ILAN·Filed 2005·Application pending·0 cites
- 2736US2007020329A1Methods of formulating linezolidTENENGAUZER RUTH·Filed 2006·Application pending·0 cites
- 2834US2003022921A1Stable pharmaceutical formulation comprising torsemide modification IIFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ruth Tenengauzer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →